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Abstract. Disorders of the oral mucosa are considered easy 
to diagnose since they can be visualized and examined 
directly. A change in the color of the oral mucosa reflects 
histopathological changes and is an important diagnostic 
parameter. However, the subjective perception of color varies. 
To determine the extent of resection for oral mucosa condi-
tions, it is necessary to digitize the color and perform objective 
assessments. In recent years, fluorescence visualization 
devices and analysis software that measure tissue luminance 
G have been employed for the identification of oral mucosa 
diseases. Fluorescence visualization is presumably based on 
the decrease in epithelial flavin adenine dinucleotide content 
and luminance G values due to the destruction of collagen 
cross‑links [fluorescence visualization loss (FVL)]. However, 
cases with differences between luminance values and histo-
pathological presentation exist. Therefore, additional factors 
may affect fluorescence visualization. The present study used 
a portable, non‑contact oral mucosa fluorescence visualization 
device for luminance measurements in seven patients with 
oral squamous cell carcinoma. Furthermore, Picro-Sirius 
Red and immunohistochemical staining were performed 
for CK13, CK17, Ki67, p53 and E‑cadherin in the FVL(+) 
(lesion) and FVL(‑) (resection stump) areas to elucidate the 
principle of fluorescence visualization. Fluorescence was 
significantly lower in the FVL(+) than in the FVL(‑) areas, and 
the mean luminance G value was 56. The Picro-Sirius Red 
stain revealed collagen destruction in the FVL(+) areas but 
no collagen disruption in the FVL(‑) areas. CK13 was nega-
tive in the FVL(+) and positive in the FVL(‑) areas, whereas 
the opposite pattern was observed for CK17. In the FVL(+) 
area, p53 staining was positive. E-cadherin expression was 
enhanced in the FVL(‑) areas and reduced in the FVL(+) 
areas. Furthermore, the luminance G value tended to be lower 
in cases with weaker E-cadherin staining. The aforementioned 
results suggest that decreased E-cadherin expression may be a 
factor that regulates fluorescence visualization.
Introduction
The early diagnosis and treatment of oral squamous cell carci-
noma (OSCC) significantly affects the prognosis and quality 
of life of patients. The change in the color of the mucous 
membrane is the most important diagnostic parameter for oral 
mucosa disorders, because it reflects histopathological altera-
tions. However, the subjective perception of color varies even 
when different individuals simultaneously observe the same 
color. Because the human brain does not have the capacity to 
accurately reproduce information about color, it is difficult 
to objectively record color changes. The appropriate iden-
tification of color associated with an oral mucosa lesion for 
diagnostic purposes requires digitization of colors and their 
evaluation as objective data. The determination of the extent 
of excision of precancerous and OSCC lesions that should be 
undertaken is often done by vital staining with iodine solu-
tion (1); however, this approach also relies substantially on the 
subjective assessment made by technicians.
The relationship between reduced tissue autofluorescence 
and epithelial malformations has been reported in recent years 
with the advancements made in optical engineering. Therefore, 
fluorescence visualization devices have been widely used as 
auxiliary diagnostic tools and have contributed significantly 
to the diagnosis and treatment of pathological conditions of 
the oral mucosa. The diagnostic instrument, VELscope® 
(DenMat), used for the oral mucosa was developed in 2006; 
it uses the difference in visible light reflected by the mucous 
membrane and has been applied clinically (2‑4). This device 
visualizes lesions via the irradiation of narrow-band blue light 
(400‑460 nm) that enables light emission by collagen matrix or 
flavin adenine dinucleotide (FAD). Tumors and inflammatory 
processes are indicated by reduced FAD levels and fluores-
cence visualization loss (FVL) due to collagen cross‑link 
(CCL) destruction. An oral mucosa fluorescence visualization 
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device that uses an optical instrument and an analysis software 
calculating its G value has also been developed in Japan and has 
been examined for its usefulness in distinguishing lesions (5). 
However, there are cases characterized by differences between 
the luminance values and histopathological presentation, 
which have led to the hypothesis that a factor other than the 
described principle of fluorescence visualization exists.
In the present study, we aimed to elucidate the principle 
of fluorescence visualization. We used a portable, non‑contact 
oral mucosa fluorescence visualization device to perform fluo-
rescence visualization and obtain luminance measurements of 
pathologically altered oral mucosa; furthermore, we carried out 
Picro-Sirius Red staining of CCL and immunohistochemical 
staining for CK13, CK17, Ki67, p53, and E-cadherin.
Materials and methods
Subjects. Oral squamous cell carcinoma was fluorescently 
visualized and histopathologically assessed in seven patients 
examined at the Department of Oral Surgery, Tokyo Dental 
College, Suidobashi Hospital between April 2017 and 
August 2018. Patients with distant metastases at the time of 
clinical examination or those receiving preventive radiotherapy 
or chemotherapy were excluded from the study. This study 
was conducted with the approval of the Tokyo Dental College 
Ethics Committee (approval no. 759). Informed consent was 
obtained from all the participants. And this informed consent 
included consent to participate in the study and consent to 
publish their images. The patient characteristics are detailed 
in Table I.
Device. Fluorescent visualization of oral mucosa was 
conducted with IllumiScan® (SHOFU Inc.). It is a lightweight 
(~320 g), portable device that allows one‑handed operation. 
IllumiScan® functions in a similar manner as an intraoral 
camera, capturing a fluorescent image of the observed intra-
oral site, saving it as digital data, and displaying the fluorescent 
image on a screen, which enables multiple observers to view it 
simultaneously (Fig. 1).
Method for color measurements of fluorescence images
Fluorescent visualization principle and assessment param-
eters. IllumiScan® enables the fluorescent visualization of oral 
mucosa through the observation of autofluorescence emitted 
by healthy mucosal cells. Fluorophores, such as the coenzyme 
FAD in the mucosal epithelium and CCLs in the stroma are 
excited by blue excitation light to generate bright green fluo-
rescence. Cells with premalignant or malignant lesions or with 
abnormalities in the TCA cycle exhibit a decreased content 
of the above-mentioned epithelial or stromal fluorophores 
in comparison with healthy cells, which is consequently 
revealed as decreased fluorescence (a loss of fluorescence). 
More specifically, a loss of FAD fluorescence occurs in oral 
premalignant lesions, whereas in OSCC, a loss of FAD or CCL 
fluorescence is observed. Such fluorescence variations were, 
therefore, used for the objective assessment of oral mucosa in 
the present study.
Excitation light and fluorescence wavelength. Oral tissue 
fluoresces when illuminated with the excitation light emitted 
from IllumiScan®. The horizontal axis in Fig. 2 indicates the 
wavelengths at which FAD and CCLs fluoresce, whereas the 
vertical axis shows the excitation wavelengths at which FAD 
and CCLs are excited to generate fluorescence. The range of 
these wavelengths was plotted as a circle and an ellipse for 
FAD and CCLs, respectively. A light gray zone in the figure 
indicates a band of the excitation wavelengths (peak: 425 nm) 
at which the tissue was illuminated. FAD and CCLs were 
excited at wavelengths in the range where the circle (for FAD) 
or ellipse (for CCLs) areas overlap with the light gray zone; as 
a result, FAD and CCLs fluoresced at wavelengths in the range 
designated as a band of fluorescence‑generated. The tissue was 
observed through the fluorescence filter of IllumiScan®, which 
blocks the intense reflection of the excitation light (upper limit: 
~450 nm). Therefore, we assessed fluorescence within a band 
of fluorescence‑observable wavelengths shown as a gray zone 
in the figure, using the image analysis software described 
below (Fig. 2).
Analysis of fluorescence intensity using an image analysis 
software. The basic operation of our image analysis soft-
ware is described below. An intraoral fluorescence image 
(1,920x1,080 pixels) captured by the camera integrated in the 
IllumiScan® body was loaded onto the image analysis software 
on a personal computer (PC) to display the image down-
sized to 960x540 pixels. For each pixel of the image, RGB 
element values [a color representation with R (red), G (green), 
and B (blue), each with values ranging from 0 to 255] were 
provided; the G value indicated the intensity of the green color 
at an arbitrary point in the fluorescence image. The analysis 
software also provided: The ratio between two mean G values 
obtained from selected regions in two different fluorescence 
images; an image showing gradients based on G values; selec-
tion of an area of concern (lesion area) to be analyzed; and the 
ratio between G values inside and outside of the selected area. 
The gradient expressed in the present study was computed as 
follows: The mean G value of a total of 25 pixels including a 
target pixel (5x5=25, a region‑of‑interest) in an intraoral fluo-
rescence image on the PC was calculated and treated as a target 
intensity value in the region. Similarly, the mean G value was 
calculated for each of the eight surrounding regions adjacent to 
the region-of-interest and treated as an adjacent intensity value 
for each surrounding region. The mean of absolute values of 
differences between the target intensity value and each of 
the adjacent intensity values was calculated and treated as a 
gradient value.
Method for the measurement and evaluation of G values. The 
measured area was defined as a circle with a 30‑pixel diameter. 
For subjects with an oral mucosa disease, G values at three 
arbitrary points from a lesion area and a lesion-free area were 
measured, and the respective mean G values were calculated 
for lesion and lesion-free areas. The ratio of the mean G value 
from the lesion area versus that from the lesion-free area was also 
calculated. For healthy subjects, we measured G values in specific 
regions of oral mucosa, i.e., the tongue (lingual edge, sublingual 
surface, and dorsum of the tongue), the floor of the oral cavity, 
buccal mucosa, upper and lower lip mucosa, and maxillary and 
mandibular gingiva, excluding the lingual frenulum and median 
palatine suture because of abundant expression of keratinized 
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tissue and resultant tendency for more intensive fluorescence. 
Furthermore, for the determination of the extent of lesion resec-
tion, we compared an iodine‑unstained area (identified by the 
conventional iodine staining method) to an image produced by 
the fluorescence visualization method described in the present 
study.
Measurement environment. The measurement of fluorescence 
was performed in a standardized clinical environment, where 
natural and artificial lighting could be blocked.
Resection method. Fluorescence light was irradiated onto 
the area of resection (resection range) of OSCC to mark the 
extent of FVL and the iodine‑unstained area; the resection was 
performed under general anesthesia by considering the posi-
tion that was 5 mm from the outermost circumference of FVL 
as the resection stump. The resection specimen was fixed in 
an extended position and marked to confirm the extent of FVL 
on the tissue specimen. Histopathological assessments were 
performed by hematoxylin and eosin (H&E) and immunohis-
tochemical staining (CK13, CK17, Ki67, p53, and E‑cadherin) 
of the FVL(+) area and the resection stump FVL(‑) as well as 
by Picro-Sirius Red staining to examine the CCL.
Histopathological assessment. Approximately 4‑mm thick 
slices were prepared from the paraffin‑embedded blocks of 
resected tissue, and one slice was subjected to H&E staining, 
Table I. Clinical information.
Case Age, years Sex Site Type
  1 62 Male Left tongue Endophytic growth
  2 43 Female Left tongue Endophytic growth
  3 59 Male Left tongue Endophytic growth
  4 73 Male Left tongue Superficial growth
  5 76 Female Left tongue Superficial growth
  6 66 Male Right tongue Superficial growth
  7 64 Male Left tongue Endophytic growth
Figure 1. Device (IllumiScan®). (A) Oral mucosa visualization device used in the present study. (B) Method used for fluorescence visualization.
Figure 2. Principle of fluorescence visualization. Excitation light for 
irradiation and wavelength of the generated f luorescence. NADH, 
nicotinamide adenine dinucleotide; FAD, flavin adenine dinucleotide.
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whereas the others were subjected to CK13, CK17, Ki67, 
p53, and E-cadherin staining as well as to Picro-Sirius Red 
staining. The following antibodies were employed: Monoclonal 
anti‑CK13 (Dako, F7), monoclonal anti‑CK17 (Dako, E3), 
monoclonal anti‑Ki67 (Dako, clone MB‑1), and monoclonal 
anti‑p53 (Dako, clone p53). Processing was performed using 
an automatic stainer (Autostainer 48; Ventana). All the cases 
included basal oral epithelial cells, which showed nuclear posi-
tivity, as positive controls. In negative controls, the primary 
antibody was omitted. The percentage of positive nuclei in 400 
consecutive epithelial cells in the selected areas representative 
of the lesion was determined and provided a semi-quantitative 
evaluation of the immunohistochemical results. The assess-
ment method reported by Shiozaki et al (6) was used to 
evaluate the expression. The entire specimen was observed; 
samples with protein expression in the cell membrane similar 
to that in the FVL(‑) area (the positive control) were regarded 
to be strongly accumulated, whereas samples that showed 
protein expression in an even, weak staining pattern were 
considered to be accumulated; no protein expression over the 
entire specimen was considered to be negative. Picro-Sirius 
Red staining was performed by deparaffinizing the samples, 
incubating them with phosphomolybdic acid for 2 min and 
Picro-Sirius Red F3BA staining solution for 60 min, and 
treating them with 0.1 N hydrochloric acid for 2 min and with 
70% ethanol for 45 sec. The color of collagen was determined 
in the three categories as proposed by Aparna and Charu (7) 
and its density was evaluated. The assessments were performed 
by two pathologists.
Statistical analysis. The paired t-test was used to assess the 
statistical significance of differences between the samples. 
P<0.05 was considered to indicate a statistically significant 
difference.
Results
Clinical information. This study included seven patients with 
squamous cell carcinoma of the tongue. There were five male 
and two female individuals, and the mean age of the subjects 
was 55 years (range, 43‑76 years). On the basis of observa-
tion of the disease, two patients had granular tumors, two had 
diffuse tumors, two had a mix of vitiligo and diffuse tumors, 
and one patient had a vitiligo-type tumor. The detailed clinical 
information for all the patients is presented in Table I.
G value measurements. The G values for the FVL(+) and 
FVL(‑) areas in the tumors of each subject are shown Fig. 3. 
The G values for the FVL(+) area ranged between 33 and 72, 
with a mean of 56, whereas those for the FVL(‑) area were 
between 136 and 158, with a mean of 147. There were statisti-
cally significant differences between the two groups (Fig. 4). 
The fluorescence luminance G was lower than 80 in the 
FVL(+) areas and higher than 130 in the FVL(‑) areas for all 
the subjects (Fig. 3).
Histopathological assessment. The FVL(+) area showed 
destruction of collagen and roughness in the Picro-Sirius Red 
staining, whereas the FVL(‑) area did not show any disruption 
of the collagen arrangement. However, collagen exhibited a 
slightly rough pattern in the FVL(+) areas in cases 3, 4 and 7. All 
specimens showed category 1 (reddish‑orange) birefringence. 
Figure 3. Results of fluorescence luminance in patients with oral mucosal disease. FVL(+), fluorescence visualization loss; FVL(‑), no fluorescence 
visualization loss.
Figure 4. Comparison of G values for the FVL(+) and FVL(‑) areas. There 
was a statistically significant difference between the two groups (P=0.0001). 
FVL(+), fluorescence visualization loss; FVL(‑), no fluorescence visualization 
loss.
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Although there was pronounced CCL destruction, its extent 
varied for the different cases. The staining for CK13 was 
negative in the FVL(+) areas and positive in the FVL(‑) areas, 
whereas the opposite was true for CK17. The expression of p53 
was positive in the FVL(+) areas. The expression of Ki67 was 
positive throughout the entire epithelium for the FVL(+) areas 
and was only noted in the basal cell layer for the FVL(‑) areas. 
Extensive staining was observed for E‑cadherin in the FVL(‑) 
Figure 5. Left‑sided tongue cancer in a 62‑year‑old male. (A) Image of the oral cavity. (B) Fluorescence visualization. (C) Histopathological assessment. H&E, 
CK13, CK17, Ki67, p53 and E‑cadherin staining (magnification, x40), and Picro‑Sirius Red staining (magnification, x200). FVL(+), fluorescence visualization 
loss; FVL(‑), no fluorescence visualization loss; H&E, hematoxylin and eosin; SCC, squamous cell carcinoma.
Figure 6. Left‑sided tongue cancer in a 59‑year‑old male. (A) Image of the oral cavity. (B) Fluorescence visualization. (C) Histopathological assessment. H&E, 
CK13, CK17, Ki67, p53 and E‑cadherin staining (magnification, x40), and Picro‑Sirius Red staining (magnification, x200). FVL(+), fluorescence visualization 
loss; FVL(‑), no fluorescence visualization loss; H&E, hematoxylin and eosin; SCC, squamous cell carcinoma.
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area but was sparse in the FVL(+) area in all the subjects. The 
luminance G value tended to be lower in the subjects with 
weaker E‑cadherin staining in the FVL(+) area (Figs. 5 and 6; 
Table II).
Discussion
Oral squamous cell carcinoma is one of the common malig-
nancies with significant morbidity and mortality. Its metastatic 
and invasive potential results in poor prognosis. Oral squa-
mous cell carcinoma is often associated with loss of eating and 
speech functions, disfigurement, and psychological distress. 
The primary treatment for this disease is surgical interven-
tion. Despite considerable advances in treatment over the past 
two decades, the overall disease outcome has improved only 
modestly (8). Local tumor recurrence affects approximately 
60% of patients, and metastases develop in 15‑25% (9). The 
prevention and management of oral squamous cell carcinoma 
will greatly benefit from the identification of molecular 
biomarkers and therapeutic targets for the disease (10,11).
Many cases of OSCC occur in readily visualized areas, and 
the disease has, therefore, been regarded as easy to diagnose. 
In the past, the condition was clinically diagnosed only by 
visual observation and palpation followed by cytological and 
histological examination. However, a variety of pathological 
conditions of the oral mucosa, such as leukoplakia, oral lichen 
planus, oral candidiasis, and aphthous stomatitis, may be very 
difficult to differentiate from early‑stage cancer simply by 
visual observation owing to similarities in their clinical presen-
tation. In recent years, a simple and feasible vital staining by 
iodine and toluidine blue has been employed, which report-
edly facilitates the disease staging and diagnosis of advanced 
epithelial dysplasia and early-stage cancer. However, this 
approach cannot be applied in all cases and in particular in 
outpatients due to restrictions, such as patient discomfort and 
allergies to the staining solutions (1).
However, the advancement of optical engineering in recent 
years has significantly contributed to the diagnosis and treat-
ment of various oral mucosa diseases including oral cancer. 
Since 2008, researchers from North America have attempted 
to develop new methods based on optical approaches for the 
examination and diagnosis of oral cancer. Optical instru-
ments, such as the magnifying endoscope NBI® (Narrow Band 
Imaging) system (12‑14) and VELscope® (DenMat) (2‑5), have 
been introduced for use in non-invasive and early discovery of 
OSCC. The NBI® system is an image enhancement technology 
that was jointly developed by Olympus Medical Systems and 
the Department of Gastroenterological Endoscopy, National 
Cancer Center Hospital East. It clearly visualizes the vascular 
structure and minute changes in the mucosal surface layer 
by irradiation with light in two narrow spectral widths of 
415 and 540 nm, through a narrow band filter, which is strongly 
absorbed by hemoglobin. As a result, the system clearly 
depicts the intraepithelial papillary capillary loop present in 
the superficial layer of the mucous membrane, thereby, serving 
as an indicator to diagnose malignancies, including esopha-
geal and oral cancer. Because this system is expensive, large, 
and requires partial sterilization despite being a non-contact 
device, it is not easy to install, and its widespread deployment 
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The portable optical instrument manufactured by Shofu 
Inc., which was used in the present study, irradiates the surface 
with a 425‑nm blue light and enables the visualization of oral 
mucosal diseases. Using this instrument, an image analysis soft-
ware that digitized the color of the mucous membrane (G value) 
was developed to obtain objective data that cannot be acquired 
with vital staining and conventional fluorescence visualization 
devices (5). As a result, minute changes in fluorescence that could 
not be recognized by visual inspection could be recorded in a 
digitized form, and color changes, otherwise unrecognizable by 
direct observation, could be detected by the software. Although 
the principle of fluorescence visualization is presumably related 
to the decrease in FAD levels and destruction of CCL, based on 
clinical experience with presented cases for which the results 
of fluorescence visualization did not match the pathology, we 
inferred that some other factor is also implicated. Therefore, in 
the present study, we focused on immunohistochemical staining 
of CK13, CK17, Ki67, p53, and E-cadherin, especially on the 
cell adhesion molecule, E-cadherin.
Cell adhesion molecules include members of the immuno-
globulin superfamily, integrin superfamily, and cadherin family. 
Among them, E-cadherin, which plays a central role in the adhe-
sion between epithelial cells, is expressed in epithelial tissues, 
and is a classic cadherin involved in the formation of adherence 
junctions. It binds to intracellular β- and γ-catenin and to the 
cytoskeleton, including α‑catenin and actin filaments (15). In 
normal stratified squamous epithelium, E‑cadherin is observed 
in the stratum basale and stratum spinosum, but not in the basal 
lamina. In recent years, cancer infiltration and metastases have 
been attributed to epithelial‑mesenchymal transition (EMT) of 
epithelial tumor cells, which leads to the loss of their epithelial 
characteristics and migration through the stroma in a dissemi-
nated manner. E-cadherin has been used as an epithelial 
marker in the assessment of EMT, and its attenuation or disap-
pearance is considered an indicator of complete EMT (16,17). 
The reduced expression of the E-cadherin and catenin family 
members is observed in a variety of cancer types and is strongly 
associated with infiltration, metastasis, and prognosis (18,19). 
Schipper et al (20) reported that the abnormal expression of 
E-cadherin in head and neck squamous cell carcinoma was 
related not only to the degree of cancer differentiation but also 
to the presence or absence of cervical lymph node metastases; 
furthermore, similar results were reported for OSCC (21). In 
these studies, approximately 50% of the subjects presented 
with attenuated E-cadherin expression. However, to the best of 
our knowledge, there are no reports on the relationship between 
E‑cadherin expression and fluorescence visualization.
In the present study, the G value was higher in the FVL(‑) 
areas than in the FVL(+) areas for all subjects for whom 
fluorescence visualization was conducted. Furthermore, the 
Picro-Sirius Red staining revealed no CCL destruction in 
the FVL(‑) areas, whereas the extent of CCL destruction in 
the FVL(+) areas varied with the subject. CK13 expression 
was positive in normal oral mucosa and negative in intraepi-
thelial tumors, whereas the opposite tended to be true for CK17 
expression. All seven subjects in the present study showed the 
same results. Because there is a positive correlation between 
the expression level of Ki67 and tumor malignancy, it would 
be useful as a marker for the detection of proliferating cells in 
tumor tissues. Furthermore, p53 has a very short half-life in 
normal cells, and is not present in quantities that would result in 
positive immunostaining. E-cadherin was expressed extensively 
in the FVL(‑) areas. In contrast, although the FVL(+) areas had 
lower G values than the FVL(‑) areas in all the subjects, the 
expression of E-cadherin was attenuated regardless of the extent 
of CCL destruction. Furthermore, subjects with strong attenua-
tion of E-cadherin expression tended to have low G values.
Even though the number of specimens examined in this 
study was small and relationship to local recurrence was not 
been studied, the results suggest the involvement of attenu-
ation of E-cadherin expression regardless of the decrease in 
G value and extent of CCL destruction as a factor contrib-
uting to the principle of fluorescence regulation, in addition 
to a decrease in FAD level and destruction of CCL. It is 
our ultimate goal to use this device for setting the surgical 
margins for oral squamous cell carcinoma. The present 
study describes a preliminary step in this direction. And we 
would need to conduct further studies on a larger number 
of patients to validate our results, particularly regarding the 
relationship between the histopathological appearances and 
the G value.
In conclusion, the results of this study suggest that a 
decrease in the luminance G value in oral mucosal fluorescence 
visualization is related to the cell adhesion factor, E-cadherin, 
and that this may contribute to a new principle underlying the 
regulation of fluorescence from oral mucosa.
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